Humeau Laurent (CIK 1770390) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Buy INO (6,027 shares), Sell INO (2,163 shares), Buy INO (4,771 shares), Sell INO (1,712 shares), Buy INO (5,010 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 6,027 | $0 |
| 2026-05-21 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 2,163 | $2,660 |
| 2026-05-18 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 4,771 | $0 |
| 2026-05-18 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 1,712 | $2,226 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 5,010 | $0 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 2,064 | $3,695 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 7,366 | $0 |
| 2026-02-27 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 3,034 | $5,431 |
| 2025-05-16 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 4,771 | $0 |
| 2025-05-16 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 1,708 | $3,331 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 3,855 | $0 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 1,584 | $3,136 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Buy | 5,010 | $0 |
| 2025-02-28 | INOVIO PHARMACEUTICALS, INC. (INO) | Chief Scientific Officer | Sell | 2,059 | $4,077 |
Source: SEC Form 4 filings · as of 2026-05-21